OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 97
- −9 vs. Q1 2025
- Portfolio value
- $3.98B
- −$187.0M (−4.5%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SVASinovac Biotech Ltd | SHS | 2,718,735 | $334.0M | 8.4% | 00.0% | Unchanged | History |
| BSXBoston Scientific Corp | Stock | 2,813,200 | $302.2M | 7.6% | 00.0% | Unchanged | History |
| LLYEli Lilly & Co | Stock | 337,600 | $263.2M | 6.6% | 00.0% | Unchanged | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 15,518,492 | $203.4M | 5.1% | +496,771+3.3% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 7,959,538 | $159.7M | 4.0% | 00.0% | Unchanged | History |
| ISRGIntuitive Surgical Inc | COM NEW | 291,000 | $158.1M | 4.0% | 00.0% | Unchanged | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 8,288,510 | $144.6M | 3.6% | 00.0% | Unchanged | History |
| SYKStryker Corp | Stock | 359,200 | $142.1M | 3.6% | 00.0% | Unchanged | History |
| EWEdwards Lifesciences Corp | Stock | 1,708,000 | $133.6M | 3.4% | +176,000+11.5% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 208,000 | $114.7M | 2.9% | +1,300+0.6% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 341,900 | $111.5M | 2.8% | −4,200−1.2% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 336,300 | $104.9M | 2.6% | +135,100+67.1% | Added | History |
| NTRANatera, Inc. | COM | 593,434 | $100.3M | 2.5% | +46,434+8.5% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 210,287 | $93.6M | 2.4% | +50,387+31.5% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 465,000 | $81.8M | 2.1% | 00.0% | Unchanged | History |
| CAICaris Life Sciences, Inc. | COM | 3,034,858 | $81.1M | 2.0% | +3,034,858 | New | History |
| IRONDisc Medicine, Inc. | COM | 1,415,020 | $74.9M | 1.9% | 00.0% | Unchanged | History |
| AVBPArriVent BioPharma, Inc. | COM | 3,027,328 | $65.9M | 1.7% | 00.0% | Unchanged | History |
| SIONSionna Therapeutics, Inc. | COM | 3,704,959 | $64.3M | 1.6% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 5,693,589 | $62.5M | 1.6% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 438,540 | $55.1M | 1.4% | −496,100−53.1% | Reduced | History |
| ITGRInteger Holdings Corp | COM | 433,400 | $53.3M | 1.3% | −229,100−34.6% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,812,886 | $51.5M | 1.3% | 00.0% | Unchanged | – |
| CGONCG Oncology, Inc. | COM | 1,877,850 | $48.8M | 1.2% | −594,144−24.0% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 2,578,979 | $48.5M | 1.2% | −863,874−25.1% | Reduced | History |
| MBXMBX Biosciences, Inc. | COM | 4,002,887 | $45.7M | 1.1% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 427,900 | $44.7M | 1.1% | +41,200+10.7% | Added | History |
| CMPXCompass Therapeutics, Inc. | COM | 15,219,994 | $39.6M | 1.0% | −7,142,856−31.9% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 1,077,000 | $35.6M | 0.9% | −432,205−28.6% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,149,000 | $33.0M | 0.8% | +150,000+15.0% | Added | History |
| EXASExact Sciences Corp | COM | 607,316 | $32.3M | 0.8% | −72,500−10.7% | Reduced | History |
| THRDThird Harmonic Bio, Inc. | COM | 5,779,071 | $31.4M | 0.8% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 2,779,427 | $31.3M | 0.8% | +2,779,427 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 947,877 | $29.7M | 0.7% | 00.0% | Unchanged | History |
| NPCENeuroPace Inc | COM | 2,614,184 | $29.1M | 0.7% | −792,151−23.3% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 7,165,006 | $28.7M | 0.7% | +221,352+3.2% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 7,562,971 | $28.2M | 0.7% | 00.0% | Unchanged | History |
| JANXJanux Therapeutics, Inc. | COM | 1,210,300 | $28.0M | 0.7% | +451,734+59.6% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,482,300 | $25.7M | 0.6% | +50,000+3.5% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,199,300 | $24.9M | 0.6% | +547,272+83.9% | Added | History |
| SCPHscPharmaceuticals Inc. | COM | 6,059,528 | $23.1M | 0.6% | 00.0% | Unchanged | History |
| CTMXCytomX Therapeutics, Inc. | COM | 8,461,500 | $19.2M | 0.5% | +8,461,500 | New | History |
| TMOThermo Fisher Scientific Inc. | Stock | 46,500 | $18.9M | 0.5% | −82,500−64.0% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 557,900 | $18.6M | 0.5% | +232,400+71.4% | Added | History |
| TRVITrevi Therapeutics, Inc. | COM | 3,308,400 | $18.1M | 0.5% | +2,188,400+195.4% | Added | History |
| ADCTADC Therapeutics SA | SHS | 5,907,351 | $15.8M | 0.4% | −61,100−1.0% | Reduced | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 248,512 | $15.7M | 0.4% | −131,488−34.6% | Reduced | History |
| FBRXForte Biosciences, Inc. | COM NEW | 1,196,955 | $15.5M | 0.4% | +603,867+101.8% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,923,855 | $14.5M | 0.4% | 00.0% | Unchanged | History |
| KROSKeros Therapeutics, Inc. | COM | 1,018,734 | $13.6M | 0.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 1,641,906 | $13.1M | 0.3% | +1,641,906 | New | History |
| 0000000000 | Stock | 12,048,773 | $13.1M | 0.3% | 00.0% | Unchanged | – |
| FOLDAmicus Therapeutics, Inc. | COM | 2,285,400 | $13.1M | 0.3% | 00.0% | Unchanged | History |
| VIRVir Biotechnology, Inc. | COM | 2,380,715 | $12.0M | 0.3% | +132,466+5.9% | Added | History |
| ABCLAbCellera Biologics Inc. | COM | 3,344,568 | $11.5M | 0.3% | −836,200−20.0% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 211,300 | $11.3M | 0.3% | +31,400+17.5% | Added | History |
| MLYSMineralys Therapeutics, Inc. | COM | 760,351 | $10.3M | 0.3% | +760,351 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 1,031,400 | $9.82M | 0.2% | +16,789+1.7% | Added | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 6,830,300 | $9.77M | 0.2% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 899,281 | $9.13M | 0.2% | +199,281+28.5% | Added | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 416,900 | $9.05M | 0.2% | +416,900 | New | History |
| PRLDPrelude Therapeutics Inc | COM | 10,909,256 | $8.83M | 0.2% | 00.0% | Unchanged | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 1,172,287 | $8.09M | 0.2% | 00.0% | Unchanged | History |
| ZLABZai Lab Ltd | ADR | 231,000 | $8.08M | 0.2% | +231,000 | New | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 197,900 | $8.02M | 0.2% | −455,843−69.7% | Reduced | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 4,166,000 | $7.79M | 0.2% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 804,603 | $7.70M | 0.2% | −948,228−54.1% | Reduced | History |
| ACETAdicet Bio, Inc. | COM | 11,447,140 | $6.98M | 0.2% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 700,000 | $6.98M | 0.2% | +700,000 | New | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 6,475,291 | $6.86M | 0.2% | 00.0% | Unchanged | History |
| URGNUroGen Pharma Ltd. | COM | 478,400 | $6.55M | 0.2% | +478,400 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 34,400 | $5.94M | 0.1% | +34,400 | New | History |
| ALMSAlumis Inc. | COM | 1,926,423 | $5.78M | 0.1% | +1,926,423 | New | History |
| JBIOJade Biosciences, Inc. | COM NEW | 531,163 | $5.31M | 0.1% | +531,163 | New | History |
| NSPRInspireMD, Inc. | COM | 2,133,405 | $4.84M | 0.1% | 00.0% | Unchanged | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 967,000 | $4.83M | 0.1% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 3,539,358 | $4.74M | 0.1% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 3,322,488 | $4.62M | 0.1% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 719,901 | $3.87M | 0.1% | −2,367,561−76.7% | Reduced | History |
| BIOABioAge Labs, Inc. | COM | 921,959 | $3.81M | 0.1% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 2,252,987 | $3.36M | 0.1% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 677,977 | $2.47M | 0.1% | −213,639−24.0% | Reduced | History |
| PASGPassage BIO, Inc. | COM | 6,055,300 | $2.42M | 0.1% | −979,326−13.9% | Reduced | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 313,200 | $2.01M | 0.1% | −34,800−10.0% | Reduced | History |
| MURAMural Oncology plc | ORD SHS | 588,800 | $1.45M | <0.1% | +588,800 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 13,459 | $1.35M | <0.1% | −15,200−53.0% | Reduced | History |
| KRYSKrystal Biotech, Inc. | COM | 9,200 | $1.26M | <0.1% | −14,300−60.9% | Reduced | History |
| TSBXTurnstone Biologics Corp. | COM | 3,099,265 | $1.11M | <0.1% | 00.0% | Unchanged | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 940,990 | $1.09M | <0.1% | −800,283−46.0% | Reduced | History |
| TRAWTraws Pharma, Inc. | COM NEW | 605,531 | $896.2K | <0.1% | 00.0% | Unchanged | History |
| KZRKezar Life Sciences, Inc. | COM | 192,700 | $882.6K | <0.1% | 00.0% | Unchanged | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 250,000 | $550.0K | <0.1% | 00.0% | Unchanged | History |
| DHAIDih Holding US, Inc. | CL A | 1,915,000 | $469.0K | <0.1% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 51,727 | $457.3K | <0.1% | +51,727 | New | History |
| KRROKorro Bio, Inc. | COM | 32,400 | $404.7K | <0.1% | 00.0% | Unchanged | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 80,420 | $375.6K | <0.1% | 00.0% | Unchanged | History |
| Lakeshore Biopharma Co LtdG9845F208 | ORD SHS NEW | 54,799 | $55.9K | <0.1% | −85,629−61.0% | Reduced | – |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2025 (23)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 3,850,200 | $97.6M | 2.3% | History |
| IONSIonis Pharmaceuticals Inc | COM | 2,540,136 | $76.6M | 1.8% | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 950,200 | $41.9M | 1.0% | History |
| XTNTXtant Medical Holdings, Inc. | COM NEW | 73,114,592 | $34.4M | 0.8% | History |
| GILDGilead Sciences, Inc. | Stock | 197,500 | $22.1M | 0.5% | History |
| VSTMVerastem, Inc. | COM NEW | 2,862,448 | $17.3M | 0.4% | History |
| RAPTRAPT Therapeutics, Inc. | COM | 13,135,260 | $16.0M | 0.4% | History |
| AMGNAmgen Inc | Stock | 44,200 | $13.8M | 0.3% | History |
| VERAVera Therapeutics, Inc. | CL A | 481,065 | $11.6M | 0.3% | History |
| SLRNACELYRIN, Inc. | COM | 4,001,711 | $9.88M | 0.2% | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 250,000 | $6.23M | 0.1% | History |
| SRRKScholar Rock Holding Corp | COM | 151,800 | $4.88M | 0.1% | History |
| BCAXBicara Therapeutics Inc. | COM | 298,301 | $3.89M | 0.1% | History |
| CBLLCeribell, Inc. | COM | 112,500 | $2.16M | 0.1% | History |
| TILInstil Bio, Inc. | COM NEW | 116,785 | $2.03M | <0.1% | History |
| CRDFCardiff Oncology, Inc. | COM | 573,884 | $1.80M | <0.1% | History |
| XFORX4 Pharmaceuticals, Inc | COM | 6,776,515 | $1.60M | <0.1% | History |
| NKTXNkarta, Inc. | COM | 821,400 | $1.51M | <0.1% | History |
| FATEFate Therapeutics Inc | COM | 1,680,580 | $1.33M | <0.1% | History |
| HLSQTessera Defense & Homeland Security Inc. | COM NEW | 1,787,767 | $993.5K | <0.1% | History |
| TNGXTango Therapeutics, Inc. | COM | 550,000 | $753.5K | <0.1% | History |
| IVVDInvivyd, Inc. | COM | 933,500 | $565.0K | <0.1% | History |
| NXTCNextCure, Inc. | COM | 1,141,200 | $548.1K | <0.1% | History |